Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons
about
Drug-drug interactions during antiviral therapy for chronic hepatitis CPersonalized medicine using DNA biomarkers: a reviewVariation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection.HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms.Current management of hepatitis C virus infection in patients with HIV co-infectionHuman immunodeficiency virus and liver disease forum 2012.Impact of hepatitis coinfection on hospitalization rates and causes in a multicenter cohort of persons living with HIV.Virological efficacy and safety of antiretroviral therapy-switch to atazanavir-based regimen: a review of the literature.New developments in the management of hepatitis C virus infection: focus on boceprevir.Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection.Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.
P2860
Q26864887-2038E058-03E0-4449-8376-A31347A53D4CQ27022319-7F753F71-D0FB-49B5-BF4F-23294ACA5782Q34796111-281AEC1D-F114-41CC-9683-C922023AD080Q36379622-E570E2C0-699A-483A-AE75-461CF3569FCDQ36590774-7F6DEA89-9176-4D37-A67C-0C30DA23A268Q37361082-B4F0F34F-6194-4491-957F-B640D61291F7Q37706753-D0F04D7F-63E7-423D-813F-52818953773DQ38050815-272069A5-62B4-41E9-90BA-213EF0BC3290Q42200489-DE00FF28-AD1A-4B15-A8B6-5903434FED97Q42255783-D0C26FCF-8151-45A9-B408-E831B4B4FD80Q44369266-29D69C49-E677-45B1-BBFD-9546843F770F
P2860
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Provisional guidance on the us ...... itis C in HIV-infected persons
@ast
Provisional guidance on the us ...... itis C in HIV-infected persons
@en
type
label
Provisional guidance on the us ...... itis C in HIV-infected persons
@ast
Provisional guidance on the us ...... itis C in HIV-infected persons
@en
prefLabel
Provisional guidance on the us ...... itis C in HIV-infected persons
@ast
Provisional guidance on the us ...... itis C in HIV-infected persons
@en
P2093
P2860
P356
P1476
Provisional guidance on the us ...... itis C in HIV-infected persons
@en
P2093
David L Thomas
John G Bartlett
Kenneth E Sherman
Marion G Peters
Mark S Sulkowski
Paul A Pham
P2860
P304
P356
10.1093/CID/CIR882
P407
P577
2012-02-04T00:00:00Z